2017
DOI: 10.1080/00365521.2017.1369560
|View full text |Cite
|
Sign up to set email alerts
|

Single center validation of mortality scores in patients with acute decompensation of cirrhosis with and without acute-on-chronic liver failure

Abstract: In this population without access to appropriate ICU treatment, the CLIF-C ACLF and AD performed worse than in studies with patients having ICU access. In addition, the CLIF scores were not superior to classical ones in this setting.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

2
9
1

Year Published

2019
2019
2024
2024

Publication Types

Select...
9

Relationship

0
9

Authors

Journals

citations
Cited by 17 publications
(12 citation statements)
references
References 21 publications
2
9
1
Order By: Relevance
“…HE at admission was observed in 31.7% of patients included in this study. is number is similar to that reported by the CANONIC (34%) and NACSELD (33%) cohorts [17,18] but lower than that reported by Alexopoulou et al [19]. ese differences are probably explained by the specific characteristics of the cohorts (differences in the aetiology and severity of HE) and difficulty in diagnosing minimal HE and by the fact that patients were evaluated very early after admission in this study.…”
Section: Discussionsupporting
confidence: 88%
“…HE at admission was observed in 31.7% of patients included in this study. is number is similar to that reported by the CANONIC (34%) and NACSELD (33%) cohorts [17,18] but lower than that reported by Alexopoulou et al [19]. ese differences are probably explained by the specific characteristics of the cohorts (differences in the aetiology and severity of HE) and difficulty in diagnosing minimal HE and by the fact that patients were evaluated very early after admission in this study.…”
Section: Discussionsupporting
confidence: 88%
“…The mortality rate in AD patients was higher than that in other studies (25.5% vs. 3.39%-10% and 32.78% vs. 5.33%-24% at 30 days and 90 days, respectively) [3,28,[31][32][33][34]. It should be noted that the 30-day mortality rate in AD patients from our study was greater than 15%, which was a threshold definition of high short-term mortality for ACLF [2].…”
Section: Plos Onecontrasting
confidence: 57%
“…In addition to bacterial infection, the CLIF-AD score and CTP score were found to be potential parameters that correlated with 90-day mortality. However, their predictive accuracies were unsatisfactory, and even the CLIF-C AD score, which was excellent according to the EASL working group [ 33 ] and has been validated by several studies [ 31 , 32 , 41 , 42 ], became statistically nonsignificant after multivariate analysis. As there are no current initial parameters that could adequately predict prognosis in severe AD patients, novel biomarkers to detect impairment of cellular metabolism early are needed.…”
Section: Discussionmentioning
confidence: 99%
“…CLIF-C AD was also developed by the CANONIC group of investigators [28], using the following parameters: age, INR, serum creatinine, and leukocyte count. Other [53][54][55], but not all [50], studies have disclosed similar findings. Our results report a good ability of CLIF-C AD to predict in-hospital mortality in cirrhotic patients admitted to the ICU with AD of cirrhosis, per definition without ACLF.…”
Section: Discussionmentioning
confidence: 57%